www.nature.com
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy - Nature Communications
Metabolic complications are common in patients suffering PCOS, including obesity, insulin resistance and type-2 diabetes. Here the authors show the efficacy of GLP1-based multi-agonists, and superiori...